•Casemix-based budget impact analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in the Netherlands
•Subcutaneous infliximab as a maintenance option in pediatric IBD: a real-world cohort including younger and lower-weight children
•International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials
•Mesenchymal Stem Cells and Their Exosomes as Novel Modulators of Gut Microbiota: Therapeutic Perspectives for Liver Diseases and Inflammatory Bowel Disease
•Hudi enteric-coated capsules promote colonic mucosa restoration via modulation of Wnt/β-catenin signaling in inflammatory bowel disease